Matthias Boentert

Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment

Josef Priller, Alexander Flügel, Tim Wehner et al. · Nature Medicine · 2001 · 630 citations

Inflammation, Optogenetics, Neuroregeneration +15

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 169 citations · Full text

Late-onset Pompe Disease, Autoimmune Disease, Clinical Infectious Disease +3

Effect of High‐Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis

Albert C. Ludolph, Johannes Dorst, Jens Dreyhaupt et al. · Annals of Neurology · 2019 · 159 citations

Prevalence of sleep apnoea and capnographic detection of nocturnal hypoventilation in amyotrophic lateral sclerosis

Matthias Boentert, Christian Glatz, Cornelia Helmle et al. · Journal of Neurology Neurosurgery & Psychiatry · 2017 · 90 citations

Neurofilament light‐chain response during therapy with antisense oligonucleotide tofersen in <scp>SOD1</scp>‐related <scp>ALS</scp>: Treatment experience in clinical practice

Thomas Meyer, Peggy Schumann, Patrick Weydt et al. · Muscle & Nerve · 2023 · 89 citations · Full text